Comments on GLOBE and GUARD drug pricing models Pharmaceutical & Drug Policy Comments on GLOBE and GUARD drug pricing models Richard G. Frank, Kristi Martin, Rachel Sachs March 2, 2026
Comments on the Transparency in Coverage proposed rule Health Care Policy Comments on the Transparency in Coverage proposed rule Matthew Fiedler, Yihan Shi February 25, 2026
Comments on the 2027 Medicare Part C and D Advance Notice Health Care Policy Comments on the 2027 Medicare Part C and D Advance Notice Matthew Fiedler February 23, 2026
Bound by quota: Drug shortage vulnerability for Schedule II medicines Pharmaceutical & Drug Policy Bound by quota: Drug shortage vulnerability for Schedule II medicines Marta E. Wosińska, Ben Graham February 23, 2026